Abstract:SHPT is one of the most common complications of CKD-MBD. Recent studies indicate that oxyphil cell proliferation is related to SHPT progression, while not inhibited by current treatments. The aim of this study was to analyze the correlation between oxyphil cell and clinical indicators in SHPT, further explore the protein expression differences of oxyphil cell. Among 33 MHD patients, 84.8% patients have one or more oxyphil dominant glands and the overall oxyphil cells proportion was 39.5 +/- 16.3%. Univariate correlation and multivariable linear regression model showed that oral calcitriol dosage and treatment duration were independently correlated to oxyphil cell ratio. Proteomic study showed that mitochondrial protein, protein synthesis, and cell cycle regulation were significantly altered in oxyphil cell nodules. DBP was downregulated in oxyphil nodules on protein level, which may contribute to calcitriol resistance by reducing vitamin D transport. Through KEGG and PPI network analysis, Wnt signaling, TGF-beta, ubiquitin mediated proteolysis and cell cycle pathways were significantly enriched in oxyphil cell nodules. Among which, MIF-CUL1 axis was significantly increased. These results suggest that the limitations of vitamin D in SHPT treatment is closely related to oxyphil cell and may be attributed to the dysregulation of vitamin D transport and ubiquitin regulation of oxyphil cell. Significance: Secondary hyperparathyroidism in end stage renal patients is one of the major challenges nephrology field faces. Emerging data indicate that oxyphil cell may participate in the pathophysiology of secondary hyperparathyroidism, while both calcimimetics and vitamin D receptor activators treatments are underperformed in controlling oxyphil cell proliferation. In the present study, we validated that the proliferation of oxyphil cells is associated with calcitriol treatment, and discovered that oxyphil cell nodules were significantly different from chief cells nodules in protein expression of mitochondria, protein synthesis and cell cycle regulation. It is noteworthy that DBP was downregulated in oxyphil nodules on protein level and may therefore participate in the resistance of calcitriol therapy by reducing the vitamin D transport capacity. Wnt signaling, TGF-13, ubiquitin mediated proteolysis and cell cycle pathways were significantly enriched in oxyphil cell nodules, among which, MIF-CUL1 axis may play an important role in the regulation of oxyphil proliferation and calcitriol resistance through ubiquitin mediated proteolysis. These results suggest that calcitriol treatment has limitations in oxyphil cell predominant SHPT, which may be attributed to the dysregulation of vitamin D transport and ubiquitin regulation of oxyphil cell, and the influence of microenvironment in uremia status may be the underlying reason.

Klotho/FGF23 and Wnt in SHPT Associated with CKD Via Regulating Mir-29A.

PTH Regulation by the Klotho/FGF23 Axis in CKD

Effects Of Fgf-23-Mediated Erk/Mapk Signaling Pathway On Parathyroid Hormone Secretion Of Parathyroid Cells In Rats With Secondary Hyperparathyroidism

Identification of key biomarkers based on the proliferation of secondary hyperparathyroidism by bioinformatics analysis and machine learning

RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Screening and validation of molecules associated with secondary hyperparathyroidism

Klotho/FGF23 axis mediates high phosphate‐induced vascular calcification in vascular smooth muscle cells via Wnt7b/β‐catenin pathway

Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis

Comparative Proteomic Analysis of Chief and Oxyphil Cell Nodules in Refractory Uremic Hyperparathyroidism by Itraq Coupled LC-MS/MS

Parathyroid Hormone-Potentiated Connective Tissue Growth Factor Expression In Human Renal Proximal Tubular Cells Through Activating The Mapk And Nf-Kappa B Signalling Pathways

Relationship Between Cfgf23/klotho Ratio and Phosphate Levels in Patients with Chronic Kidney Disease

Interrelated Role of Klotho and Calcium-Sensing Receptor in Parathyroid Hormone Synthesis and Parathyroid Hyperplasia.

Upstream and Downstream Regulators of Klotho Expression in Chronic Kidney Disease

Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients

Parathyroid Hormone Induces Epithelial-to-mesenchymal Transition Via the Wnt/β-catenin Signaling Pathway in Human Renal Proximal Tubular Cells.

Evidence For Chronic Kidney Disease-Mineral And Bone Disorder Associated With Metabolic Pathway Changes

Mild Chronic Kidney Disease Associated with Low Bone Formation and Decrease in Phosphate Transporters and Signaling Pathways Gene Expression

Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease

Fibroblast Growth Factor 23, Klotho and Heparin

Klotho Regulates Epithelial-to-Mesenchymal Transition in Vitro Via Wnt/β-Catenin Pathway and Attenuates Chronic Allograft Dysfunction in a Rat Renal Transplant Model.

Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects